Cutis laxa
MONDO:0016175Cutis laxa (CL) is an inherited or acquired connective tissue disorder characterized by wrinkled, redundant and sagging inelastic skin associated with skeletal and developmental anomalies and, in some cases, with severe systemic involvement. Several different forms of inherited CL have been described, differentiated on the basis of the mode of inheritance and differences in the extent of internal organ involvement, associated anomalies and disease severity.
Also known as: cutis laxa, elastolysis, generalised elastolysis, generalized elastolysis
34 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New antibiotic cocktails take on tough UTIs and kidney infections
Disease control CompletedThis phase 3 trial tested two new antibiotic combinations—cefepime/nacubactam and aztreonam/nacubactam—against a standard antibiotic (imipenem/cilastatin) in 614 adults with complicated urinary tract infections or acute kidney infections. The goal was to see if the new combos are…
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Ultrasound eyebrow lift shows promise in clinical trial
Symptom relief CompletedThis completed clinical trial tested a high-intensity focused ultrasound (HIFU) device called ULTRAFORMER MPT for lifting eyebrows without surgery. 180 adults aged 20-65 with mild to moderate forehead skin laxity received either a single HIFU treatment or no treatment. The study …
Phase: NA • Sponsor: CLASSYS Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Filler combo aims to restore cheek volume after weight loss
Symptom relief CompletedThis study tested whether combining two types of dermal fillers—Sculptra and Restylane—can improve cheek volume, wrinkles, and skin quality in 41 adults with moderate-to-severe cheek aging. Participants had a history of weight loss or were taking GLP-1 medications. They received …
Phase: NA • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Could a blood pressure drug improve daily life for rare disease survivors?
Symptom relief CompletedThis study tested whether the drug Northera (droxidopa) is safe and helpful for adults with Menkes disease or Occipital Horn Syndrome who have trouble with low blood pressure and other symptoms of dysautonomia. Three participants took either the drug or a placebo in a crossover d…
Phase: PHASE1, PHASE2 • Sponsor: Stephen G. Kaler, MD • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New device aims to smooth wrinkles without surgery
Symptom relief CompletedThis study tested a micro-coring device that removes small pieces of skin to reduce moderate to severe cheek wrinkles. Thirty adults aged 40 to 70 participated. Researchers measured wrinkle improvement at 90 days and tracked any side effects.
Phase: NA • Sponsor: Cytrellis Biosystems, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Can a night cream really tighten skin and smooth wrinkles?
Symptom relief CompletedThis study tested a topical cream called DMAE Oleate on 30 healthy adults aged 40 to 55 who had visible fine lines, wrinkles, and loose skin. Participants applied the cream at night for 12 weeks. Researchers measured changes in crow's-feet wrinkles and skin firmness using special…
Phase: NA • Sponsor: Bionos Biotech S.L. • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
One-Time radiofrequency treatment may lift jawline without surgery
Symptom relief CompletedThis study tested whether a single session of radiofrequency treatment with continuous water cooling could improve jawline contour and facial volume in 22 women aged 38-50. Participants received one treatment and were followed for 8 weeks. The goal was to see if the device could …
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New skin device shows promise for wrinkle and pigment reduction
Symptom relief CompletedThis completed trial tested the BTL-785F device on 39 healthy adults over 30 who wanted better skin on their face and neck. Participants received three treatments, each lasting 20–60 minutes, spaced 2–6 weeks apart. The goal was to see if the device could improve skin texture, re…
Phase: NA • Sponsor: BTL Industries Ltd. • Aim: Symptom relief
Last updated Jun 26, 2026 17:30 UTC
-
Tiny skin study checks if renuvion device tightens and rejuvenates face
Knowledge-focused CompletedThis small study looked at skin samples from 7 people having a lower facelift to see if adding Renuvion APR treatment improves skin elasticity, hydration, and biological age. Researchers compared treated and untreated skin areas before and 180 days after surgery. The goal was to …
Phase: NA • Sponsor: Apyx Medical • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Gene sequencing uncovers mysterious fetal malformations
Knowledge-focused CompletedThis study tested whether a powerful DNA test called high-throughput exome sequencing can find genetic causes of multiple birth defects in fetuses when standard exams fail. Researchers studied 100 fetuses with at least two malformations and no prior diagnosis. They compared the n…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Speedy gene test aims to give answers on birth defects in just 7 days
Knowledge-focused CompletedThis study tested whether a fast type of genetic test called rapid genome sequencing can find the cause of birth defects seen on ultrasound more quickly than current methods. Researchers included 184 pregnancies with certain ultrasound findings. The goal was to see if results cou…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC